Table 3 Percentage increase in gap between relative Loss of Lifetime performance ratings for PSA and No PSA screening options needed to produce equipoise for each 4 cluster solution, by age group
| Â | 40-49 years | 50-59 years | 60-69 years | |||
|---|---|---|---|---|---|---|
| Â | % Change | %N | % Change | %N | % Change | %N |
Moderate Lifers | 0.1 | 35 | 2.7 | 27 | 4.1 | 26 |
Very High Lifers | 0.0 | 25 | 0.3 | 24 | 0.4 | 14 |
Equals | 0.4 | 32 | 3.5 | 41 | 21.5 | 44 |
Very High Sexers | 0.2 | 8 | 14.4 | 8 | … | … |
Moderate Biopsers | … | … | … | … | 45.4 | 15 |